Priyangi A. Malaviarachchi
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Priyangi A. Malaviarachchi's research focuses on understanding infectious diseases and the immune system's response. Her work includes investigating the pathogenesis of SARS-CoV-2, examining its impact on disease severity in specific populations, and evaluating antiviral drug efficacy using precision-cut lung slice platforms. Malaviarachchi also studies the immune mechanisms involved in combating bacterial infections, such as pneumonic plague and Chlamydia, with a focus on the role of specific cytokines like IFNγ and Interleukin-17 in host defense and inflammation.
Her publications explore the complex interactions between different pathogens and the host, including co-infections with viruses like Kaposi's Sarcoma-Associated Herpesvirus and SARS-CoV-2. Malaviarachchi collaborates with researchers at the University of Arkansas for Medical Sciences, including Srijon K. Banerjee, Lin-Xi Li, Miguel A. B. Mercado, and Wuying Du, contributing to a shared body of work in medical research. She has authored 24 publications with an h-index of 7 and 451 citations.
Metrics
- h-index: 7
- Publications: 24
- Citations: 451
Selected Publications
- Alterations in Cellular Gene Expression Due to Co‐Infection With Kaposi's Sarcoma‐Associated Herpesvirus and SARS‐CoV‐2: Implications for Disease Severity (2024) DOI
- An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy (2024) DOI
- SARS-CoV-2 Infection Causes Heightened Disease Severity and Mortality in a Mouse Model of Down Syndrome (2024) DOI
- Pulmonary Expression of Interleukin-17 Contributes to Neutrophil Infiltration into the Lungs during Pneumonic Plague (2023) DOI
- An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy (2023) DOI
- IFNγ and Antibody Synergize To Enhance Protective Immunity against Chlamydia Dissemination and Female Reproductive Tract Reinfections (2022) DOI
- IFNγ and antibody synergize to enhance protective immunity against <i>Chlamydia</i> dissemination and female reproductive tract reinfections (2022) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics